Niccolò Bolli, MD, PhD, University of Milan, Milan, Italy, talks on the role of the bone marrow (BM) immune microenvironment in response or resistance to immunotherapy in patients with multiple myeloma. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.